Brandi Roberts

Brandi Roberts currently serves as the Chief Financial Officer at Longboard Pharmaceuticals since January 2021 and is a Board Member at both TFF Pharmaceuticals, Inc. and Temple Therapeutics BV. Previously, Brandi held the Chief Financial Officer position at Lineage Cell Therapeutics and REVA Medical, Inc. and worked as a Financial Consultant supporting a transition at Savara. Brandi's early career includes serving as Chief Financial Officer at Mast Therapeutics, Vice President of Accounting and Corporate Controller at Alphatec Spine, and Vice President of Finance at ADVENTRX Pharmaceuticals. Educational qualifications include an MBA in Business from the University of San Diego and a BSBA in Accounting and Finance from the University of Arizona.